Cancer Rehab Awareness Week Campaign

 

PINC&STEEL Cancer Rehabilitation Foundation NZ are proud to launch the details of the first ever worldwide ‘Cancer Rehab Awareness Week Campaign'

There are so many people missing out on cancer rehab services due to a real lack of awareness. This has to change to minimise the risk of preventable long-term disability and suffering for anyone affected by cancer.

The objective of the Awareness Week is to reach more people with information about cancer rehabilitation, so that no one misses out on optimal recovery after a cancer diagnosis. 

The side-effects of cancer and cancer treatment are real but often it’s only the survivors and their loved ones who know the ongoing difficulties cancer treatment can bring. Difficulties that can be helped, if only people knew! No one should be left to rehabilitate from the effects of treatment alone.

The Cancer Rehab Awareness Week is scheduled for the 7th to 13th September 2020 and is supported by hundreds of cancer rehab physiotherapists and occupational therapists worldwide alongside several major cancer organisations who are keen to raise awareness too.

To learn more about the plans and events happening in Cancer Rehab Awareness Week, and to join in to support the campaign or fundraise for the PINC&STEEL Cancer Rehabilitation Foundation in NZ, join our Facebook page https://www.facebook.com/pincandsteel/ and check out the updates here https://www.pincandsteel.com/raise-awareness/

PantoCIN Trial

Trial Design

The PantoCIN trial will test the ability of a cheap, widely available drug to prevent two of chemotherapy’s most unpleasant side-effects: delayed nausea and vomiting.

This study explores whether a commonly used medication called pantoprazole can help prevent delayed nausea and vomiting from chemotherapy for early breast cancer.

Delayed nausea, and occasionally vomiting, can occur after breast cancer chemotherapy, affecting the quality of life. A potential cause of these delayed side effects is that the chemotherapy may cause stomach irritation. Pantoprazole is commonly used to treat stomach irritation by reducing stomach acid, which may, in turn, improve nausea and/or vomiting.

Patients undergoing breast cancer chemotherapy before or after primary surgery will be invited to participate in the study. They will be asked how much nausea or vomiting they have with and without pantoprazole from day two until five after they receive chemotherapy. All participants will still receive all of the usual anti-sickness medications, which are very effective in preventing sickness in the first 24 hours after treatment, but not for delayed symptoms.

Information from the study may lead to a change in practice with patients using pantoprazole to reduce the risks of delayed nausea and vomiting.

The PantoCIN trial, lead by medical oncologists Richard Isaacs and Navin Wewala from Palmerston North Hospital, will recruit 160 patients at up to ten hospitals around New Zealand.

Recruiting sites: Auckland, Hamilton, Tauranga, Rotorua, Palmerston North, Wellington, Christchurch, Dunedin, New Plymouth, Hawkes Bay and Whangarei.

Please click her for full trial information.

Results (reported 2023)

The results showed that pantoprazole is effective as a prophylactic treatment against delayed chemotherapy-induced nausea and vomiting in patients receiving adjuvant or neoadjuvant beast cancer chemotherapy. Read more here.

 

Subscribe to %1